Johan M Kros

发表

Fast Tracking of Co‐Localization of Multiple Markers by Using the Nanozoomer Slide Scanner and NDPViewer

Ping-Pin Zheng, Marcel van der Weiden, Johan M Kros, 2014, Journal of cellular physiology.

Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis

Naoki Kagawa, Naoya Hashimoto, Toshihiro Kumabe, 2016, The Lancet. Oncology.

CAR T cell therapies : ice bucket challenges on glaring safety risks and long-term impacts

Ping-Pin Zheng, Johan M Kros, J. Kros, 2018 .

Identification of Tumor‐Related Proteins by Proteomic Analysis of Cerebrospinal Fluid from Patients with Primary Brain Tumors

Rob Pieters, Ping-Pin Zheng, Theo M Luider, 2003, Journal of neuropathology and experimental neurology.

Phase II study of imatinib in patients with recurrent gliomas of various histologies: a European Organisation for Research and Treatment of Cancer Brain Tumor Group Study.

Denis Lacombe, Johan M Kros, R. Stupp, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene expression profiles associated with treatment response in oligodendrogliomas.

Jord H A Nagel, Mathilde C M Kouwenhoven, Peter van der Spek, 2005, Cancer research.

Cell proliferation and migration are mutually exclusive cellular phenomena in vivo: Implications for cancer therapeutic strategies

Ping-Pin Zheng, Rob Willemsen, Marcel van der Weiden, 2009, Cell cycle.

Panel Review of Anaplastic Oligodendroglioma From European Organization for Research and Treatment of Cancer Trial 26951: Assessment of Consensus in Diagnosis, Influence of 1p/19q Loss, and Correlations With Outcome

Caterina Giannini, Ping-Pin Zheng, Felice Giangaspero, 2007, Journal of neuropathology and experimental neurology.

Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951.

Winand N M Dinjens, Jean-Yves Delattre, Denis Lacombe, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

Pieter Wesseling, Hendrikus J Dubbink, Winand N M Dinjens, 2010, Clinical Cancer Research.

Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

Pieter Wesseling, Peggy N Atmodimedjo, Hendrikus J Dubbink, 2016, Neuro-oncology.

Heterogeneity within the PF-EPN-B ependymoma subgroup

Martin Sill, Caterina Giannini, Hendrik Witt, 2018, Acta Neuropathologica.

A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951

Pieter Wesseling, Johan M Kros, M. J. van den Bent, 2011, Clinical Cancer Research.

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

Pieter Wesseling, Christine Haberler, Arie Perry, 2020, Brain pathology.